Image

Patients Treated in Real Life With VEnetoclax for WAldenström Macroglobulinemia

Recruiting
18 years and older
Both
Phase N/A
  • Simplified (AI rewritten)
  • Technical (Original)

Waldenström macroglobulinemia (WM) is a type of blood cancer that's currently incurable. A medicine called Venetoclax is used to treat other blood cancers like chronic lymphocytic leukemia (CLL) and acute myeloid leukemia. Venetoclax works by stopping cancer cells from avoiding death, letting the body get rid of them. In a study with 32 WM patients, 84% had their cancer respond to Venetoclax, with 81% experiencing major improvements. This study wants to see how well Venetoclax works for WM patients in France, outside of a controlled trial setting. Eligibility: To join the study, you must have WM, be treated with Venetoclax, and agree to participate. There are no exclusion criteria, which means anyone meeting these conditions can join. This study is retrospective, meaning researchers will look back at past treatments and outcomes.

  • Study looks at past treatments, not new ones.
  • No need for extra visits; it's based on existing data.
  • Findings could help improve WM treatment understanding.
Print
Study details
    Waldenstrom's Macroglobulinaemia Refractory

NCT06200220

Poitiers University Hospital

24 January 2024

Contact a study center
Not finding the right Trial?

You can also call our Patient navigators who can help you to find the right trial.

Call now
Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.